Create a narrative

Lifecore Biomedical Community

NasdaqGS:LFCR Community

1 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Lifecore Biomedical

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from Analysts

Biopharma Partnerships And Injectable Demand Will Expand Global Reach

Key Takeaways Expanding partnerships, operational enhancements, and regulatory credibility are driving Lifecore's momentum in biopharma manufacturing, supporting stronger contract wins and profitability. Rising demand for injectable and HA-based drugs, along with new market entries, is broadening Lifecore's addressable market and cementing a foundation for sustained growth.

US$10.00

FV

25.8% undervalued

11.54%

Revenue growth p.a.

0

0

0

about 20 hours ago